TP PHARMA
1028.516.932 · rovalta.com · 09/11/2026
Overview
Identity
Source · BCE/KBOTP PHARMA is a Private limited company incorporated in 2025. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Zoersel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 1028.516.932
- Incorporation
- 02/10/2025
- Legal form
- Private limited company
- Registered office
- Antwerpsedreef 2
2980 Zoersel · FlandreSee on map - Contributed capital
- 1 500,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 1 filingTrend over 1 financial year
| 2025 | |
|---|---|
| Income statement | |
| Gross margin | 346 € |
| EBITDA | 5,1 € |
| Operating result | 5,1 € |
| Balance sheet | |
| Equity | 1,5 k € |
| Total assets | 8,7 k € |
| Cash | 357,1 € |
| Debts | 7,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Tim Paumen | Bestuurdersince 02/10/2025 |
Other companies at this address
Antwerpsedreef 2 2980 Zoersel| Company | CBE no. |
|---|---|
APOTHEEK MICHIELS● Active | 0442.751.352 |
PAUMEN-MICHIELS● Active | 0473.574.685 |
Financials
Full financial information
Source · NBB| 2025 | |
|---|---|
| Type of account | Micro model |
| Start of the financial year | 02/10/2025 |
| Closing of the financial year | 31/12/2025 |
| Length of the financial year | 3 months |
| Filing date | 10/02/2026 |
| General meeting | 01/02/2026 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 1 filing| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 01/02/2026 | 10/02/2026 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Tim Paumen | Bestuurdersince 02/10/2025 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other06/10/2025RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Antwerpsedreef 2, 2980 ZoerselCurrent | accounts 2025 | Accounts 2025 · 2026-00036858 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| TP PHARMACurrent | accounts 2025 | Accounts 2025 · 2026-00036858 |
Events
- 2025Annual accounts 2025
- 02/10/2025IncorporationPrivate limited company